Progress Report: Steven Frank, MD
Investigator: Steven Frank, MD– Assistant Professor, University of Texas, M.D. Anderson Cancer Center C4 and MRI-based Prostate Brachytherapy Brachytherapy is a form of radiotherapy where a radiation source, called “seeds”,...Read More
Progress Report: Adam S. Feldman, MD, MPH
Investigator: Adam S. Feldman, MD, MPH–Assistant Professor of Surgery, Massachusetts General Hospital, Harvard School of Medicine Active Surveillance: Identifying When to Treat and When Not to Treat In 2010 nearly...Read More
Progress Report: Eleni Efstathiou, MD, Ph.D
Investigator: Eleni Efstathiou, MD, PhD – Assistant Professor, University of Texas, M.D. Anderson Cancer Center Biomarker Driven Application of Therapy Androgens (male hormones such as testosterone) fuel prostate cancer growth...Read More
Progress Report: Scott Dehm, Ph.D
Investigator: Scott Dehm, PhD – Assistant Professor, University of Minnesota Mechanisms of Androgen Receptor (AR) Activation in Prostate Cancer The standard first line treatment strategy for metastatic prostate cancer is...Read More
Progress Report: Atish Choudhury, MD, Ph.D
Investigator: Atish Choudhury, MD, PhD – Instructor in Medicine, Dana-Farber Cancer Institute Molecular Determinants of Hormone Refractory Prostate Cancer Metastatic prostate cancer initially responds to androgen deprivation therapy (ADT; blockade...Read More
Progress Report: Steve Y. Cho, MD
Investigator: Steve Y. Cho, MD – Assistant Professor, Johns Hopkins University Translation of [18F]DCFBC PET:A Novel Prostate Imaging Biomarker Positron Emission Tomography (PET) is a molecular imaging technique that can...Read More
Progress Report: Gerhardt Attard, MD, Ph.D
Investigator: Gerhardt Attard, MD, PhD – Assistant Professor, Institute for Cancer Research, Royal Marsden Hospital, London Predicting Resistance to Abiraterone: Molecular Analysis of CTCs First-line treatment for recurrent prostate cancer...Read More
Progress Report: Mohamed Simon Arredouani, Ph.D
Investigator: Mohamed Simon Arredouani, PhD – Assistant Professor, Beth Israel Deaconess Medical Center Advances in Prostate Cancer Immunotherapy The immune system protects humans and other mammals from disease by recognizing...Read More
Progress Report: Andrew Armstrong, MD, MSc
Investigator: Andrew Armstrong, MD, MSc – Associate Professor, Duke University Linking Epithelial and Stemness Plasticity with Prostate Cancer Metastasis and the Lethal Phenotype The mechanism by which cancer cells spread...Read More
Progress Report: John Ward, MD
Investigator: John Ward, MD– Assistant Professor, M.D. Anderson Cancer Center, University of Texas Noninvasive Radiofrequency Field for the Targeted Destruction of Prostate Cancer Using Directed Gold Nanoparticles—Activated Gold Particles Could...Read More